REMOTE Modeling and Simulations Senior / Principal Scientist role US BASED

Overview: The position is within the Integrative Systems Biology group, which blends quantitative pharmacology with systems biology. It supports both pre-clinical and clinical drug development and focuses on population PK modeling and exposure-response simulations. Key Responsibilities: Perform population PK modeling independently. Collaborate with project teams to plan and execute predictive/descriptive analyses. Write modeling reports tailored to project needs. Lead internal discussions on modeling methodology and results. Stay updated on model-informed drug development trends. Ideal Candidate Profile: Education/Experience: PhD with 5+ years of experience, or MS with 10+ years of relevant pharmacometrics experience. Technical Skills: Proficient with NONMEM, Monolix, or nlmixR. Regulatory Experience: Experience contributing to regulatory filings (e.g., CTA, IND, NDA, BLA). Soft Skills: Strong communication skills, intellectual curiosity, and a collaborative mindset. What Makes This Role Unique: Team has broad expertise: QSP, PBPK, AI/ML, mechanistic PK/PD. There's an emphasis on continued learning, ideation, and interdisciplinary development. High-impact role with direct contribution to drug development strategies. Other roles I am working on: Sr. Dir. Pharmacometrics (US Based East Coast)-Global Relocation is provided. International candidates currently interviewing Dir. Pharmacometrics (US Based East Coast)-Global Relocation is provided. International candidates currently interviewing Associate Director / Director Clinical Pharmacology (East Coast) - Relocation Provided TJ Elder President Clinical Pharmacology / Pharmacometrics O: 413.458.6124 C: 413.207.7676 https://www.linkedin.com/in/tjelder/ [email protected]<mailto:[email protected]> [cid:[email http://www.stem-sourcing.com/ Please Note: The information in this e-mail message is legally privileged and confidential information intended only for the use of the addressee(s) named above. If you, the reader of this message, are not the intended recipient, you are hereby notified that you should not further disseminate, distribute, or forward this e-mail message. If you have received this e-mail in error, please notify the sender as soon as possible. In addition, please delete the erroneously received message from any device/media where the message is stored.